Thursday 30 January
Please note that this is the preliminary programme; times and titles are still subject to change.
08.30 - 9:00 Plenary III - Seeding assays for alphasynuclein
Alison Green (Edinburgh, UK)
09.00 - 09.30 Plenary IV - Co-pathology in DLB
David Irwin (Pennsylvania, USA)
09.30 - 09.45 SHORT BREAK
09.45 - 11.15 Symposium IV - Fluid biomarkers
Chairs: Charlotte Teunissen & Brit Mollenhauer
Katharina Bolsewig - DOPA Decarboxylase: High discriminative power in CSF, but confounded by treatment in blood
Jodi Maple-Grødem - Predicting Dementia in Parkinson’s Disease: Insights from α-Synuclein SAA, NfL, Aβ, and GCase Biomarkers
Carla Abdelnour - Diagnostic accuracy of plasma biomarkers for detecting amyloidosis in alpha-synucleinopathies
Elena Vera Campuzano - Differential Associations of plasma NfL and Cognitive Performance in Lewy Bodies Disease Patients with and without Alzheimer’s Disease Co-Pathology
James Leverenz - The US Dementia with Lewy Bodies Consortium: Description and Insights on the Performance of CSF Synuclein Aggregation Assay
11.15 - 11.45 COFFEE Break
11.45 - 13.15 Symposium V - Imaging/neurophysiology biomarkers
Chairs: Dani Ferreira & Laura Bonnani
Oral presentations:
Christina Tremblay - Prediction of phenoconversion in isolated REM sleep behavior disorder using free water imaging: a longitudinal, multicentre, prospective cohort study
Matej Perovnik - The dementia with Lewy bodies related metabolic brain pattern expression in patients with dementia with Lewy bodies, Alzheimer dementia and Parkinson disease dementia: a multicentric study
Angeliki Zarkali - Glymphatic dysfunction contributes to development of cognitive impairment in Parkinson’s independently from white matter degeneration
Bastiaan GJ Tol - Pathways for the progression of neurodegeneration in dementia with Lewy bodies
Anita D'Anselmo - Increased functional coupling of EEG pre-alpha rhythms in patients with Dementia with Lewy Bodies
13.15 - 14.30 LUNCH/Poster session
14.30 - 16.00 Symposium VI - Biological classification and DLB
- NSD-ISS
Tatyana Simuni (Chicago, USA) - SyNeurGe
Anthony Lang (Toronto, Canada) - ATN-classification, lessons learned from Alzheimer’s disease
Philip Scheltens (Amsterdam, NL) - Biological classification from DLB perspective
Bradley Boeve (Minnesota, USA)
16.00-16.30 BREAK
16.30-17.30 Panel discussion
"How is Lewy body dementia related to other
neurodegenerative disorders”
Chairs: John-Paul Taylor & Jim Leverenz